Poly (ADP-ribose) polymerase (PARP) inhibitors
US8980902B2 · kind B2 · utility
2Cited by
15References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 18, 2013 |
| Grant date | Mar 17, 2015 |
| Priority date | — |
| Expiry date | Sep 22, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the following formula are provided for use with PARP:wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits, and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.